drugset / Trial / NCT00086164

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

NCT00086164 ↗

Phase 1/2 Terminated Anesiva, Inc.
RandomizedSingle-groupDouble-blindDiagnostic

Summary

The purpose of this study is to determine the effect of recipient vein pretreatment of edifoligide (E2F Decoy), compared to placebo, on graft/recipient vein stenosis in polytetrafluoroethylene (PTFE) vascular access grafts placed for hemodialysis at 6 months after enrollment.

Timeline

Start
2004-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CGT003 Unknown — —